BCMA/GPRC5D bispecific CAR T-cell therapy for relapsed/refractory multiple myeloma with extramedullary disease: a single-center, single-arm, phase 1 trial. - Yao, Hao; Ren, Shi-hui; Wang, Lin-hui; Ren, Ming-qiang; Cai, Jiao; Chen, Dan; He, Ying; Lai, Si-han; Dou, Bai-tao; Li, Meng-jiao; Li, Yan-ling; Cen, Ya-li; et al. (Journal of Hematology & Oncology, 2025)